JPH01156658A - Biosensor - Google Patents
BiosensorInfo
- Publication number
- JPH01156658A JPH01156658A JP62316610A JP31661087A JPH01156658A JP H01156658 A JPH01156658 A JP H01156658A JP 62316610 A JP62316610 A JP 62316610A JP 31661087 A JP31661087 A JP 31661087A JP H01156658 A JPH01156658 A JP H01156658A
- Authority
- JP
- Japan
- Prior art keywords
- layer
- mediator
- soln
- electrode
- enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000005259 measurement Methods 0.000 claims abstract description 12
- 108090000854 Oxidoreductases Proteins 0.000 claims abstract description 7
- 102000004316 Oxidoreductases Human genes 0.000 claims abstract description 7
- 239000012528 membrane Substances 0.000 claims description 6
- 108090000790 Enzymes Proteins 0.000 abstract description 24
- 102000004190 Enzymes Human genes 0.000 abstract description 24
- 229940088598 enzyme Drugs 0.000 abstract description 24
- -1 potassium ferricyanide Chemical compound 0.000 abstract description 8
- 239000007788 liquid Substances 0.000 abstract description 7
- 108010015776 Glucose oxidase Proteins 0.000 abstract description 6
- 239000004366 Glucose oxidase Substances 0.000 abstract description 6
- 229940116332 glucose oxidase Drugs 0.000 abstract description 6
- 235000019420 glucose oxidase Nutrition 0.000 abstract description 6
- 239000000758 substrate Substances 0.000 abstract description 6
- 229920002134 Carboxymethyl cellulose Polymers 0.000 abstract description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 abstract description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 abstract description 3
- 239000008112 carboxymethyl-cellulose Substances 0.000 abstract description 3
- 239000001913 cellulose Substances 0.000 abstract description 3
- 229920002678 cellulose Polymers 0.000 abstract description 3
- 239000012295 chemical reaction liquid Substances 0.000 abstract description 2
- 238000001035 drying Methods 0.000 abstract description 2
- 239000008363 phosphate buffer Substances 0.000 abstract description 2
- 238000013508 migration Methods 0.000 abstract 1
- 230000005012 migration Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 22
- 239000008103 glucose Substances 0.000 description 22
- 239000000523 sample Substances 0.000 description 8
- 239000012488 sample solution Substances 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 5
- 238000010586 diagram Methods 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 230000001590 oxidative effect Effects 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000002860 competitive effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 239000000276 potassium ferrocyanide Substances 0.000 description 2
- XOGGUFAVLNCTRS-UHFFFAOYSA-N tetrapotassium;iron(2+);hexacyanide Chemical compound [K+].[K+].[K+].[K+].[Fe+2].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] XOGGUFAVLNCTRS-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000003411 electrode reaction Methods 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000007650 screen-printing Methods 0.000 description 1
Abstract
Description
【発明の詳細な説明】
産業上の利用分野
本発明は、種々の試料中の特定成分を迅速かつ容易に、
定量することのできるバイオセンサに関するものである
。DETAILED DESCRIPTION OF THE INVENTION Field of Industrial Application The present invention provides a method for quickly and easily identifying specific components in various samples.
This invention relates to a biosensor that can perform quantitative measurements.
従来の技術
近年、酵素反応と電極反応を結びつけて、試料中の特定
成分を測定するバイオセンサが利用されるようになって
きた。BACKGROUND OF THE INVENTION In recent years, biosensors have come into use that combine enzyme reactions and electrode reactions to measure specific components in samples.
以下に従来のバイオセンサについて説明する。A conventional biosensor will be explained below.
第4図は従来のバイオセンサの断面図であシ、8は絶縁
性基板、9と10は絶縁性基板8上に導電性カーボンペ
ーストをスクリーン印刷して形成した測定極と対極であ
る。11は絶縁層で、絶縁性樹脂ペーストを絶縁性基板
8.測定極9.対極10上に前記同様印刷し、電極部と
した。12はメディエータ−を前記電極部表面に塗布し
て製作したメディエータ−担持層で、1ait、メディ
エータ−担持層12上に設置された酵素固定化層である
。FIG. 4 is a cross-sectional view of a conventional biosensor, where 8 is an insulating substrate, and 9 and 10 are measurement electrodes and counter electrodes formed by screen printing conductive carbon paste on the insulating substrate 8. 11 is an insulating layer, and an insulating resin paste is applied to an insulating substrate 8. Measuring pole 9. The same printing as above was performed on the counter electrode 10 to form an electrode part. Reference numeral 12 denotes a mediator support layer prepared by applying a mediator to the surface of the electrode portion, and 1ait is an enzyme immobilization layer placed on the mediator support layer 12.
以上のように構成されたバイオセンサについて以下、そ
の動作を説明する。試料液を上部から滴下すると、まず
酵素固定化層13において(1)式に示すように試料液
中の特定成分と酸化酵素が特異的に反応する。The operation of the biosensor configured as described above will be described below. When the sample liquid is dropped from above, first, in the enzyme immobilization layer 13, a specific component in the sample liquid reacts specifically with the oxidizing enzyme as shown in equation (1).
S + E (ox)’−+P +E (red)
−・”(1)S:特定成分、E(ox):酸化型酵素P
:生成分、 E(red) :還元型酵素さらにメディ
エータ−担持層12において(2)式に示すようにメデ
ィエータ−が還元される。S + E (ox)'-+P + E (red)
-・”(1) S: Specific component, E (ox): Oxidized enzyme P
: product component, E(red) : reduced enzyme Further, in the mediator support layer 12, the mediator is reduced as shown in equation (2).
E (red)+M(0り−+E (0り+M (re
d)−・・(2)M(ox):酸化型メディエータ−
M(red):還元型メディエータ−
ここで生成した還元型メディエータ−を電極系9゜1o
上で(3)式に示すように酸化し、M(red)−+M
(o、x)+e −−−−−−−−−−−−(3)
e:電子
この酸化電流値を測定することにより試料液中の特定成
分濃度を検知する。E (red)+M(0ri-+E (0ri+M(re)
d) -... (2) M (ox): Oxidized mediator - M (red): Reduced mediator - The reduced mediator produced here is transferred to the electrode system at 9°1
The above is oxidized as shown in formula (3), and M(red)−+M
(o, x) + e −−−−−−−−−−−(3)
e: Electron By measuring this oxidation current value, the concentration of a specific component in the sample liquid is detected.
発明が解決しようとする問題点
しかしながら前記従来の構成では、酸化酵素を使用する
場合、メディエータ−担持層において前記(2)式に示
す反応と、(4)式に示すような試料液中の溶存酸素と
の競争反応が起こるため、還元型メディエータ−の生成
が阻害される。Problems to be Solved by the Invention However, in the conventional configuration, when an oxidase is used, the reaction shown in the above equation (2) occurs in the mediator-carrying layer, and the dissolution in the sample liquid as shown in the equation (4) occurs. Since a competitive reaction with oxygen occurs, the production of reduced mediator is inhibited.
E (red) +02−)E (0り +H2O2−
”・(→02:酸X、 H2O2: 過酸化水酸時ニフ
ェロセン、ベンゾキノンなどの難水溶性のメディエータ
−を使用する場合、前記(4)式の反応の影響は大きく
、高濃度の特定成分に十分対応できない。まだ、メディ
エータ−担持層12上に酵素固定化層13を形成する際
、酵素を湿式で固定化する間に、酵素とメディエータ−
の湿潤状態での共存による相互の酸化還元反応が進行し
、メディエータ−の酸化還元状態が不安定で、精度良い
測定ができないという問題点を有していた。E (red) +02-)E (0ri +H2O2-
”・(→02: Acid However, when the enzyme immobilization layer 13 is formed on the mediator support layer 12, the enzyme and mediator are still immobilized in a wet manner.
The mutual redox reaction proceeds due to the coexistence of the mediator in a wet state, and the redox state of the mediator is unstable, resulting in the problem that accurate measurements cannot be performed.
本発明は前記従来の問題点を解決するもので、酸化型メ
ディエータ−を多量に供給し、各層間を密着させること
によシ、特定成分を高濃度域まで精度良く測定できるバ
イオセンサを提供することを目的とする。The present invention solves the above-mentioned conventional problems, and provides a biosensor that can accurately measure a specific component up to a high concentration range by supplying a large amount of oxidized mediator and bringing each layer into close contact. The purpose is to
問題点を解決するだめの手段
この目的を達成するために本発明のバイオセンサは、測
定極と対極から成る電極上に酸化酵素の固定化層を設置
し、さらにその上部に水溶性メディエータ−を不溶性多
孔体膜に乾燥状態で担持した層を密着させた構成とした
ものである。Means for solving the problem In order to achieve this objective, the biosensor of the present invention has an oxidase immobilized layer placed on an electrode consisting of a measurement electrode and a counter electrode, and a water-soluble mediator is further placed on top of the immobilized layer of oxidase. It has a structure in which a layer supported in a dry state is adhered to an insoluble porous membrane.
作 用
この構成によって、バイオセンサ形成過程において酵素
とメディエータ−が湿潤状態で共存することがなく、酸
化型メディエータ−が安定に保持され精度良く測定でき
る。また、測定の際、上部から試料液を滴下すると、ま
ず水溶性メディエータ−担持層を通過し、試料液中に多
量のメディエータ−が溶解した後、酵素反応が起こるた
め試料液中の溶存酸素との競争反応の影響が減少し、特
定成分が高濃度まで測定可能となシ、さらに、各層間の
密着性が高い構造であることから、反応液の移動が円滑
に起こシ、精度良い測定が可能である。Function: With this configuration, the enzyme and the mediator do not coexist in a wet state during the biosensor formation process, and the oxidized mediator is stably retained and can be measured with high accuracy. In addition, when a sample solution is dropped from the top during measurement, it first passes through the water-soluble mediator support layer, and after a large amount of mediator is dissolved in the sample solution, an enzymatic reaction occurs, so dissolved oxygen in the sample solution and The influence of competitive reactions is reduced, making it possible to measure specific components at high concentrations.Furthermore, because the structure has high adhesion between each layer, the movement of the reaction liquid occurs smoothly, allowing for highly accurate measurements. It is possible.
実施例
以下本発明の一実施例としてのグルコースセンサについ
て、図面を参照しながら説明する。EXAMPLE Hereinafter, a glucose sensor as an example of the present invention will be described with reference to the drawings.
第1図は本発明の一実施例におけるグルコースセンサの
断面図を模式的に示すものである。第1図において、1
は絶縁性基板、2は測定極、3は対極、4は絶縁層でこ
れらは従来例の構造と同じものである。5は酵素固定化
層で、電極部2,3゜4上KO−5%カルボキシメチル
セルロース水溶液を塗布し45℃30分で恒温乾燥を行
い、電極部、!: 密着性の良い膜厚1μのカルボキシ
メチルセルロース膜を得、これを担体として、酵素溶液
であるグルコースオキシダーゼ溶液を塗布、乾燥しグル
コースオキシダーゼを固定化して作製した。FIG. 1 schematically shows a cross-sectional view of a glucose sensor according to an embodiment of the present invention. In Figure 1, 1
2 is an insulating substrate, 2 is a measurement electrode, 3 is a counter electrode, and 4 is an insulating layer, which have the same structure as the conventional example. 5 is an enzyme immobilization layer, and a KO-5% carboxymethylcellulose aqueous solution is applied on the electrode part 2,3°4 and dried at constant temperature at 45°C for 30 minutes. : A carboxymethyl cellulose membrane with a film thickness of 1 μm with good adhesion was obtained, and using this as a carrier, a glucose oxidase solution, which is an enzyme solution, was applied and dried to immobilize glucose oxidase.
6はメディエータ−担持層で、セルロース多孔体膜を担
体として、メディエータ−であるフェリンアン化カリウ
ムのリン酸塩緩衝液(pH5,6)中に含浸後乾燥して
作製したものである。7は保持枠で酵素固定化層6の上
に前記の様にして作製したメディエータ−担持層6を密
着性良く圧着し保持するだめのものである。Reference numeral 6 denotes a mediator-carrying layer, which was prepared by impregnating a porous cellulose membrane as a carrier in a phosphate buffer (pH 5, 6) containing potassium ferrinanide, which is a mediator, and then drying it. Reference numeral 7 denotes a holding frame for press-bonding and holding the mediator-carrying layer 6 produced as described above on the enzyme immobilization layer 6 with good adhesion.
以上のように構成された本実施例のグルコースセンサに
ついて、以下その動作を説明する。まず試料液を第1図
の上部に滴下すると、まずメディエータ−担持層6にお
いて水溶性のフェリシアン化カリウムが試料液中に溶解
し、高濃度のフェリシアン化カリウム溶液が生成される
。次に、メディエータ−担持層6と密着している酵素固
定化層5に速やかに溶液が移動し、酵素固定化層6にお
いて、グルコースオキシダーゼとフェリシアン化カリウ
ムの反応が前記の(1)式、?)式のように起こシ、フ
ェロシアン化カリウムが生成する。そして、酵素固定化
層5と密着している電極上でフェロシアン化カリウムの
酸化電流値を測定することによシ試料中のグルコース濃
度を検知する。The operation of the glucose sensor of this embodiment configured as described above will be described below. First, when a sample liquid is dropped onto the upper part of FIG. 1, water-soluble potassium ferricyanide is first dissolved in the sample liquid in the mediator-carrying layer 6, and a highly concentrated potassium ferricyanide solution is produced. Next, the solution quickly moves to the enzyme immobilization layer 5 that is in close contact with the mediator support layer 6, and in the enzyme immobilization layer 6, the reaction between glucose oxidase and potassium ferricyanide is carried out by the above equation (1), ? ), potassium ferrocyanide is produced. Then, the glucose concentration in the sample is detected by measuring the oxidation current value of potassium ferrocyanide on the electrode that is in close contact with the enzyme immobilization layer 5.
第2図は前記のグルコースセンサで測定した酸化電流値
とグルコース水溶液のグルコース濃度との関係を示すも
のである。Aは本発明の電極系上に酵素固定化層を設置
した上にメディエータ−担持層を密着させて形成したも
ので、Bは従来例の電極上にメディエータ−担持層を設
置した上に酵素固定化層を形成したものである。この図
よシ、Aでは電流値とグルコース濃度は5oor4/d
tまで非常に良い直線性を示しているが、これに対し従
来例のBでは、グルコース(8度が2o。FIG. 2 shows the relationship between the oxidation current value measured by the glucose sensor and the glucose concentration of the glucose aqueous solution. A is formed by placing an enzyme immobilization layer on the electrode system of the present invention and then adhering the mediator support layer, and B is a conventional electrode system in which the mediator support layer is placed on the electrode system and then the enzyme immobilization layer is formed. It has a layer formed on it. In this diagram, the current value and glucose concentration are 5oor4/d at A.
It shows very good linearity up to t, but in contrast, in conventional example B, glucose (8 degrees is 2 degrees).
d/dt以上の応答に直線性が見られないことがわかる
。これはBの構成では、メディエータ−が試料液中に十
分存在しないために、メディエータ−の還元反応(前記
C2)式)の競争区応である溶存酵素の反応(前記(4
)式)が優性となシ、メディエータ−の還元量がグルコ
ース濃度に対応しないためと考えられる。It can be seen that no linearity is observed in the response above d/dt. This is because in configuration B, the mediator is not sufficiently present in the sample solution, so the reaction of the dissolved enzyme (the above (4)
) is dominant, which is thought to be because the amount of mediator reduction does not correspond to the glucose concentration.
第3図は前記のグルコースセンサで測定した同−oグy
v−r−x水溶Hの各グルコースセンサ間おける酸化電
流値を示すものである。図中Aは前記本発明のグルコー
スセンサ、Bは前記従来のグルコースセンサである。こ
の図たシ、Aは各グルコースセンサ間での電流値のばら
つきが小さく安定した測定値を示している。しかし、B
は応苓値の平均が高く、各グルコースセンサ間の電流値
のばらつきが大きく安定に測定されていないことがわか
る。これは、酵素固定化層作製の際の湿潤状態において
、メディエータ−の還元が起こシ、試料液中のグルコー
ス量に依存しない還元メディエータ−が生成し、メディ
エータ−担持層内に酸化型と還元型メディエータ−が混
在するため測定値の平均が大きくなシ、ばらつきも増加
すると考えられる。Figure 3 shows the same glucose measured with the glucose sensor mentioned above.
It shows the oxidation current value between each glucose sensor of v-r-x aqueous H. In the figure, A is the glucose sensor of the present invention, and B is the conventional glucose sensor. In this figure, A shows a stable measured value with small variations in current value between each glucose sensor. However, B
It can be seen that the average value is high, and that the current values between each glucose sensor vary widely and are not measured stably. This is because reduction of the mediator occurs in the wet state during the preparation of the enzyme immobilization layer, and reduced mediator is generated that does not depend on the amount of glucose in the sample solution, and the oxidized and reduced mediator forms in the mediator support layer. It is thought that because of the presence of mediators, the average of the measured values is large and the variation is also increased.
以上のように、本実施例によれば電極系上にグルコース
オキシダーゼのような酸化酵素の固定化層を設置し、さ
らにその上部に水溶性メディエータ−であるフェリシア
ン化カリウムが不溶性多孔体膜であるセルロース膜に乾
燥担持された層を密着させた構成を設けたことによシ、
試料液中のグルコース量を高濃度まで精度良く測定する
ことができる。これは、測定の際、試料液中にフェリシ
アン化カリウムが多量に供給され、かつ各層間の試料反
応液の移動が円滑に行われているためと考えられる。As described above, according to this example, an immobilized layer of an oxidizing enzyme such as glucose oxidase is installed on the electrode system, and potassium ferricyanide, which is a water-soluble mediator, is placed on top of the immobilized layer of an oxidizing enzyme, such as glucose oxidase, on the cellulose, which is an insoluble porous membrane. Due to the structure in which the dry supported layer is brought into close contact with the membrane,
It is possible to accurately measure the amount of glucose in a sample solution up to a high concentration. This is thought to be because a large amount of potassium ferricyanide is supplied to the sample solution during measurement, and the sample reaction solution moves smoothly between the layers.
なお本実施例では水溶性メディエータ−としてフェリシ
アン化カリウムを用いたが、他に、フ”ルシアンプルー
ルテニウムレッド、メケレンプルーなどの色素でも良い
。In this example, potassium ferricyanide was used as the water-soluble mediator, but other dyes such as ferrician pluthenium red and mechelene blue may also be used.
発明の効果
以上のように本発明によれば、測定極と対極からなる電
極系上に酸化酵素の固定化層を設置し、さらにその上部
に水溶性メディエータ−が不溶性多孔体&に乾燥状態で
担持された層を密着させた構成とすることによシ、特定
成分を高濃度域まで精度良く測定できるという効果が得
られる。Effects of the Invention As described above, according to the present invention, an oxidase immobilized layer is provided on an electrode system consisting of a measurement electrode and a counter electrode, and a water-soluble mediator is further placed on an insoluble porous body in a dry state on top of the oxidase immobilization layer. By having a structure in which the supported layers are in close contact with each other, it is possible to obtain the effect that a specific component can be measured with high accuracy up to a high concentration range.
第1図は本発明の一実施例におけるグルコースセンt
ノ断面図、第2図はグルコースセンサノクルコース濃度
と応答電流の相関特性図、第3図は各グルコースセンサ
と応答電流の関係図、第4図は従来例におけるバイオセ
ンサの断面図である。
1・・・・・・絶縁性基板、2・・・・測定極、3・・
曲対極、4・・・・・・絶縁層、6・・・・・・酵素固
定化層、6・・川・メディエータ−担持層、7・・山・
保持枠。
代理人の氏名 弁理士 中 尾 敏 男 ほか1名1−
絶縁住幕柾
第2図
シルコース濃N (rq/a)
第3図
シルコースとンサNo。FIG. 1 shows glucose concentration in one embodiment of the present invention.
FIG. 2 is a correlation characteristic diagram between glucose sensor concentration and response current, FIG. 3 is a relationship diagram between each glucose sensor and response current, and FIG. 4 is a sectional diagram of a conventional biosensor. 1...Insulating substrate, 2...Measurement electrode, 3...
Curved counter electrode, 4...Insulating layer, 6...Enzyme immobilization layer, 6...River/mediator support layer, 7...Mountain...
holding frame. Name of agent: Patent attorney Toshio Nakao and 1 other person1-
Insulation Sumakusa Figure 2 Silcourse No. (rq/a) Figure 3 Silcourse and Nsa No.
Claims (2)
上に酸化酵素の固定化層を設置し、さらにその上部にメ
ディエーターが不溶性多孔体膜に乾燥状態で担持された
層を密着させた構成であることを特徴とするバイオセン
サ。(1) An electrode system consisting of a measurement electrode and a counter electrode is provided, a layer of immobilized oxidase is placed on top of this electrode system, and a layer in which a mediator is supported in a dry state on an insoluble porous membrane is placed on top of the layer. A biosensor characterized by having a configuration.
る特許請求の範囲第1項記載のバイオセンサ。(2) The biosensor according to claim 1, wherein the mediator is a water-soluble mediator.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62316610A JP2574347B2 (en) | 1987-12-15 | 1987-12-15 | Biosensor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62316610A JP2574347B2 (en) | 1987-12-15 | 1987-12-15 | Biosensor |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH01156658A true JPH01156658A (en) | 1989-06-20 |
JP2574347B2 JP2574347B2 (en) | 1997-01-22 |
Family
ID=18078985
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP62316610A Expired - Lifetime JP2574347B2 (en) | 1987-12-15 | 1987-12-15 | Biosensor |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2574347B2 (en) |
Cited By (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5288636A (en) * | 1989-12-15 | 1994-02-22 | Boehringer Mannheim Corporation | Enzyme electrode system |
US5508171A (en) * | 1989-12-15 | 1996-04-16 | Boehringer Mannheim Corporation | Assay method with enzyme electrode system |
US5997817A (en) * | 1997-12-05 | 1999-12-07 | Roche Diagnostics Corporation | Electrochemical biosensor test strip |
WO2003025558A1 (en) * | 2001-09-14 | 2003-03-27 | Arkray, Inc. | Method, tool and device for measuring concentration |
WO2007088811A1 (en) * | 2006-02-02 | 2007-08-09 | Tokyo University Of Marine Science And Technology | Biosensor and method for manufacturing the same |
WO2013137173A1 (en) * | 2012-03-15 | 2013-09-19 | 株式会社村田製作所 | Method for manufacturing biosensor |
US8840553B2 (en) | 1998-04-30 | 2014-09-23 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8933664B2 (en) | 2006-03-31 | 2015-01-13 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
US8974386B2 (en) | 1998-04-30 | 2015-03-10 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9017259B2 (en) | 2000-06-27 | 2015-04-28 | Abbott Diabetes Care Inc. | Integrated sample acquisition and analyte measurement device |
US9039975B2 (en) | 2006-03-31 | 2015-05-26 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
US9066695B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9078607B2 (en) | 2005-11-01 | 2015-07-14 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9234863B2 (en) | 1998-10-08 | 2016-01-12 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US9234864B2 (en) | 1997-02-06 | 2016-01-12 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US9323898B2 (en) | 2005-11-04 | 2016-04-26 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
US9498159B2 (en) | 2001-01-02 | 2016-11-22 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9668684B2 (en) | 2009-02-26 | 2017-06-06 | Abbott Diabetes Care Inc. | Self-powered analyte sensor |
US9801545B2 (en) | 2007-03-01 | 2017-10-31 | Abbott Diabetes Care Inc. | Method and apparatus for providing rolling data in communication systems |
US9962091B2 (en) | 2002-12-31 | 2018-05-08 | Abbott Diabetes Care Inc. | Continuous glucose monitoring system and methods of use |
US9980670B2 (en) | 2002-11-05 | 2018-05-29 | Abbott Diabetes Care Inc. | Sensor inserter assembly |
US10039881B2 (en) | 2002-12-31 | 2018-08-07 | Abbott Diabetes Care Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
US10201301B2 (en) | 2005-11-01 | 2019-02-12 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US10478108B2 (en) | 1998-04-30 | 2019-11-19 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
USD902408S1 (en) | 2003-11-05 | 2020-11-17 | Abbott Diabetes Care Inc. | Analyte sensor control unit |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60173459A (en) * | 1984-02-20 | 1985-09-06 | Matsushita Electric Ind Co Ltd | Biosensor |
-
1987
- 1987-12-15 JP JP62316610A patent/JP2574347B2/en not_active Expired - Lifetime
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60173459A (en) * | 1984-02-20 | 1985-09-06 | Matsushita Electric Ind Co Ltd | Biosensor |
Cited By (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5508171A (en) * | 1989-12-15 | 1996-04-16 | Boehringer Mannheim Corporation | Assay method with enzyme electrode system |
US5288636A (en) * | 1989-12-15 | 1994-02-22 | Boehringer Mannheim Corporation | Enzyme electrode system |
US9234864B2 (en) | 1997-02-06 | 2016-01-12 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
USRE43815E1 (en) | 1997-12-05 | 2012-11-20 | Roche Diagnostics Operations, Inc. | Electrochemical biosensor test strip |
US5997817A (en) * | 1997-12-05 | 1999-12-07 | Roche Diagnostics Corporation | Electrochemical biosensor test strip |
USRE41309E1 (en) | 1997-12-05 | 2010-05-04 | Roche Diagnostics Operations, Inc. | Electrochemical biosensor test strip |
USRE42560E1 (en) | 1997-12-05 | 2011-07-19 | Roche Diagnostics Operations, Inc. | Electrochemical biosensor test strip |
USRE42924E1 (en) | 1997-12-05 | 2011-11-15 | Roche Diagnostics Operations, Inc. | Electrochemical biosensor test strip |
USRE42953E1 (en) | 1997-12-05 | 2011-11-22 | Roche Diagnostics Operations, Inc. | Electrochemical biosensor test strip |
US9066697B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US10478108B2 (en) | 1998-04-30 | 2019-11-19 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9072477B2 (en) | 1998-04-30 | 2015-07-07 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8840553B2 (en) | 1998-04-30 | 2014-09-23 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9066694B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8974386B2 (en) | 1998-04-30 | 2015-03-10 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9066695B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9042953B2 (en) | 1998-04-30 | 2015-05-26 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9891185B2 (en) | 1998-10-08 | 2018-02-13 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US9341591B2 (en) | 1998-10-08 | 2016-05-17 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US9316609B2 (en) | 1998-10-08 | 2016-04-19 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US9291592B2 (en) | 1998-10-08 | 2016-03-22 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US9234863B2 (en) | 1998-10-08 | 2016-01-12 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US9271669B2 (en) | 2000-06-27 | 2016-03-01 | Abbott Diabetes Care Inc. | Method for integrated sample acquisition and analyte measurement device |
US9017259B2 (en) | 2000-06-27 | 2015-04-28 | Abbott Diabetes Care Inc. | Integrated sample acquisition and analyte measurement device |
US9662057B2 (en) | 2000-06-27 | 2017-05-30 | Abbott Diabetes Care Inc. | Integrated sample acquisition and analyte measurement method |
US9498159B2 (en) | 2001-01-02 | 2016-11-22 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9610034B2 (en) | 2001-01-02 | 2017-04-04 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
WO2003025558A1 (en) * | 2001-09-14 | 2003-03-27 | Arkray, Inc. | Method, tool and device for measuring concentration |
USRE45764E1 (en) | 2001-09-14 | 2015-10-20 | Arkray, Inc. | Concentration measuring method, concentration test instrument, and concentration measuring apparatus |
USRE44522E1 (en) | 2001-09-14 | 2013-10-08 | Arkray, Inc. | Concentration measuring method, concentration test instrument, and concentration measuring apparatus |
US9980670B2 (en) | 2002-11-05 | 2018-05-29 | Abbott Diabetes Care Inc. | Sensor inserter assembly |
US11141084B2 (en) | 2002-11-05 | 2021-10-12 | Abbott Diabetes Care Inc. | Sensor inserter assembly |
US11116430B2 (en) | 2002-11-05 | 2021-09-14 | Abbott Diabetes Care Inc. | Sensor inserter assembly |
US10973443B2 (en) | 2002-11-05 | 2021-04-13 | Abbott Diabetes Care Inc. | Sensor inserter assembly |
US10750952B2 (en) | 2002-12-31 | 2020-08-25 | Abbott Diabetes Care Inc. | Continuous glucose monitoring system and methods of use |
US10039881B2 (en) | 2002-12-31 | 2018-08-07 | Abbott Diabetes Care Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
US9962091B2 (en) | 2002-12-31 | 2018-05-08 | Abbott Diabetes Care Inc. | Continuous glucose monitoring system and methods of use |
USD914881S1 (en) | 2003-11-05 | 2021-03-30 | Abbott Diabetes Care Inc. | Analyte sensor electronic mount |
USD902408S1 (en) | 2003-11-05 | 2020-11-17 | Abbott Diabetes Care Inc. | Analyte sensor control unit |
US10201301B2 (en) | 2005-11-01 | 2019-02-12 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US10952652B2 (en) | 2005-11-01 | 2021-03-23 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US11911151B1 (en) | 2005-11-01 | 2024-02-27 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US11399748B2 (en) | 2005-11-01 | 2022-08-02 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US11363975B2 (en) | 2005-11-01 | 2022-06-21 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US11272867B2 (en) | 2005-11-01 | 2022-03-15 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US10231654B2 (en) | 2005-11-01 | 2019-03-19 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US11103165B2 (en) | 2005-11-01 | 2021-08-31 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9078607B2 (en) | 2005-11-01 | 2015-07-14 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9669162B2 (en) | 2005-11-04 | 2017-06-06 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
US11538580B2 (en) | 2005-11-04 | 2022-12-27 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
US9323898B2 (en) | 2005-11-04 | 2016-04-26 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
WO2007088811A1 (en) * | 2006-02-02 | 2007-08-09 | Tokyo University Of Marine Science And Technology | Biosensor and method for manufacturing the same |
US9743863B2 (en) | 2006-03-31 | 2017-08-29 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
US9039975B2 (en) | 2006-03-31 | 2015-05-26 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
US8933664B2 (en) | 2006-03-31 | 2015-01-13 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
US9380971B2 (en) | 2006-03-31 | 2016-07-05 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
US9625413B2 (en) | 2006-03-31 | 2017-04-18 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
US9801545B2 (en) | 2007-03-01 | 2017-10-31 | Abbott Diabetes Care Inc. | Method and apparatus for providing rolling data in communication systems |
US9668684B2 (en) | 2009-02-26 | 2017-06-06 | Abbott Diabetes Care Inc. | Self-powered analyte sensor |
US10631768B2 (en) | 2009-02-26 | 2020-04-28 | Abbott Diabetes Inc. | Self-powered analyte sensor |
WO2013137173A1 (en) * | 2012-03-15 | 2013-09-19 | 株式会社村田製作所 | Method for manufacturing biosensor |
Also Published As
Publication number | Publication date |
---|---|
JP2574347B2 (en) | 1997-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH01156658A (en) | Biosensor | |
JP3874321B2 (en) | Biosensor | |
JP3267936B2 (en) | Biosensor | |
EP0987544B1 (en) | Substrate determining method | |
US7235170B2 (en) | Biosensor | |
JP4796731B2 (en) | Creatinine biosensor | |
JPH10185860A (en) | Biosensor | |
JPH0262952A (en) | Biosensor and its production | |
JPS5816698B2 (en) | Enzyme electrode and its manufacturing method | |
JPH0136062B2 (en) | ||
JP2001330581A (en) | Substrate concentration determination method | |
JPH05340915A (en) | Biosensor and measuring method using the same | |
WO2003076919A1 (en) | Substrate determining method | |
JPS63182559A (en) | Production of enzyme electrode | |
JP3267933B2 (en) | Substrate quantification method | |
JP3024394B2 (en) | Biosensor and measurement method using the same | |
JP3437016B2 (en) | Biosensor and method of quantifying substrate using the same | |
EP0387026A2 (en) | Biosensor device | |
JPH01253648A (en) | Biosensor | |
JP2000180399A (en) | Determination method of substrate | |
JP3862779B2 (en) | Biosensor | |
JP2517151B2 (en) | Measuring method of substrate concentration by biosensor | |
JPH02231558A (en) | Enzyme sensor | |
JP2727704B2 (en) | Biosensor manufacturing method | |
JPH0652249B2 (en) | Biosensor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081024 Year of fee payment: 12 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081024 Year of fee payment: 12 |